Add to ORKGObjective Insulin glargine has been shown to be as efficacious as neutral protamine hagedorn(NPH) insulin with a lower risk of hypoglycaemia.The aim of this prospective,observational study was to describe the safety and efficacy of glargine and NPH in Chinese patients with type 2 diabetes mellitu...中华医学会、中华医学会糖尿病分会
Introduction: The First Basal Insulin Evaluation (FINE) Asia study was a prospective, observational ...
Aims: To examine treatment patterns following basal insulin (BI) introduction in type 2 diabetes mel...
Aims: To examine treatment patterns following basal insulin (BI) introduction in type 2 diabetes mel...
Background: The Observational Registry of Basal Insulin Treatment (ORBIT) study evaluated the safety...
AbstractAimsThis analysis evaluated HbA1c-adjusted hypoglycemia risk with glargine versus neutral pr...
Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality worldwide and is an impo...
Aims: To compare glucose control and safety of different basal insulin therapies (BI, including Insu...
Aims/Introduction: The primary aim of this systematic review was to provide an overview of the effic...
The aim was to observe the effects of switching from neutral protamine Hagedorn (NPH) insulin to ins...
AimsInsulin is normally added to oral glucose-lowering drugs in people with type 2 diabetes when gly...
Aims—We compared basal regimens of glargine or NPH among insulin-naïve, U.S. inner city, ethnic mino...
Aim: To explore the clinical safety and effectiveness of insulin detemir (IDet) in a subgroup of Ind...
Background: Efficacy of basal insulin (BI) has been well studied by randomized controlled trials, bu...
Background: The prevalence of type 2 diabetes mellitus (T2DM) is increasing rapidly among Chinese ad...
Background: Efficacy of basal insulin (BI) has been well studied by randomized controlled trials, bu...
Introduction: The First Basal Insulin Evaluation (FINE) Asia study was a prospective, observational ...
Aims: To examine treatment patterns following basal insulin (BI) introduction in type 2 diabetes mel...
Aims: To examine treatment patterns following basal insulin (BI) introduction in type 2 diabetes mel...
Background: The Observational Registry of Basal Insulin Treatment (ORBIT) study evaluated the safety...
AbstractAimsThis analysis evaluated HbA1c-adjusted hypoglycemia risk with glargine versus neutral pr...
Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality worldwide and is an impo...
Aims: To compare glucose control and safety of different basal insulin therapies (BI, including Insu...
Aims/Introduction: The primary aim of this systematic review was to provide an overview of the effic...
The aim was to observe the effects of switching from neutral protamine Hagedorn (NPH) insulin to ins...
AimsInsulin is normally added to oral glucose-lowering drugs in people with type 2 diabetes when gly...
Aims—We compared basal regimens of glargine or NPH among insulin-naïve, U.S. inner city, ethnic mino...
Aim: To explore the clinical safety and effectiveness of insulin detemir (IDet) in a subgroup of Ind...
Background: Efficacy of basal insulin (BI) has been well studied by randomized controlled trials, bu...
Background: The prevalence of type 2 diabetes mellitus (T2DM) is increasing rapidly among Chinese ad...
Background: Efficacy of basal insulin (BI) has been well studied by randomized controlled trials, bu...
Introduction: The First Basal Insulin Evaluation (FINE) Asia study was a prospective, observational ...
Aims: To examine treatment patterns following basal insulin (BI) introduction in type 2 diabetes mel...
Aims: To examine treatment patterns following basal insulin (BI) introduction in type 2 diabetes mel...